Keywords: supplemental, nda, filed, activase, genentech, new, drug

Supplemental NDA filed for Activase

Article | 25 March 1996

Print This

- Genentech has filed a supplemental New Drug Application in the USA for its thrombolytic drug Activase (alteplase) as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in